Nestle, Coke take cautious approach to nurturing Ozempic users By Reuters

Nestle’s New Food Brand for Weight-Loss Drug Users: Navigating Regulatory Concerns and Market Competition

Nestle, the world’s largest food maker, is stepping into the burgeoning market of food products designed for people taking weight-loss drugs such as Wegovy. This strategic move reflects a growing trend among food companies to cater to the millions of individuals using appetite suppressants. However, Nestle’s approach is marked by a careful navigation of regulatory concerns and innovative marketing strategies.


Regulatory Concerns: Keeping Drug Names Off Packaging

Nestle’s new food brand, Vital Pursuit, specifically targets consumers on weight-loss medications like Wegovy and Ozempic. Despite this clear market focus, Nestle has decided to keep the names of these blockbuster drugs off their packaging. According to Tom Moe, Nestle USA’s president of foods, this decision stems from regulatory concerns.

“We’re not going to directly link [the drugs] to the food package,” Moe told Reuters. The company aims to avoid any implication that their food products can treat or prevent disease, a claim that only products approved by the U.S. Food and Drug Administration (FDA) can make. Lauren Handel, a food attorney, emphasized the importance of this cautious approach, noting that mentioning specific medications on food packaging could suggest a misleading health benefit.


Marketing Strategies: Social Media and Influencer Engagement

Instead of direct references on packaging, Nestle plans to market its Vital Pursuit line of $5-and-under frozen meals through social media channels. This strategy leverages the power of digital marketing to reach consumers without falling afoul of regulatory guidelines. By focusing on attributes like high protein, fiber, and nutrient content, Nestle aims to attract consumers who are mindful of their nutritional needs while on weight-loss medications.

Other players in the market, such as Herbalife and Robard Corp, have adopted different approaches. Herbalife, for instance, directly mentions GLP-1 weight loss drugs in its marketing materials, while Robard Corp uses influencers to promote its Biocare drink, which is designed to mitigate the side effects of these medications.


Competition in the Market: A Growing Landscape

Nestle will face stiff competition as it launches its Vital Pursuit brand this fall. Competitors are making specific claims about their products tailored for people on weight-loss drugs. For example, Biocare’s packaging states it can “reduce side effects” for people taking semaglutide, the active ingredient in Wegovy and Ozempic. Additionally, retailers like GNC are dedicating sections in their stores to GLP-1 users, offering protein powders and fiber supplements.

Coca-Cola and Danone are also eyeing this market. Coca-Cola’s Fairlife shakes, which boast up to 42 grams of protein, are frequently promoted by individuals on social media who use weight-loss medications. Similarly, Danone highlights its yogurt products as suitable for those on these drugs due to their low sugar and high protein content.


The Future of Food for Weight-Loss Drug Users

As the market for weight-loss drugs continues to expand, food companies are keen to create new associations in consumers’ minds about what they should eat while taking these medications. Kelli Frias, a marketing professor at American University, notes that consumers currently lack clear ideas about the best dietary choices while on these drugs. Food companies are stepping in to fill this gap, aiming to establish new dietary norms and preferences.

Nestle’s cautious yet innovative approach—balancing regulatory compliance with targeted marketing—positions it well in this competitive landscape. As consumers become more educated about their nutritional needs while on weight-loss medications, brands like Vital Pursuit are poised to play a significant role in shaping their dietary habits.


Stay tuned as Nestle’s Vital Pursuit hits store freezers this fall, offering a new way for those on weight-loss drugs to manage their nutritional needs. The evolving market landscape promises exciting developments as more companies join the race to cater to this growing consumer segment.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top